Cargando…
Oncogenic signaling in amphiregulin and EGFR‐expressing PTEN‐null human breast cancer
A subset of triple negative breast cancer (TNBC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) and loss of PTEN, and patients with these determinants have a poor prognosis. We used cell line models of EGFR‐positive/PTEN null TNBC to elucidate the signaling network...
Autores principales: | Kappler, Christiana S., Guest, Stephen T., Irish, Jonathan C., Garrett-Mayer, Elizabeth, Kratche, Zachary, Wilson, Robert C., Ethier, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304881/ https://www.ncbi.nlm.nih.gov/pubmed/25454348 http://dx.doi.org/10.1016/j.molonc.2014.10.006 |
Ejemplares similares
-
Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death
por: Guest, Stephen T., et al.
Publicado: (2016) -
KAT6A, a Chromatin Modifier from the 8p11-p12 Amplicon is a Candidate Oncogene in Luminal Breast Cancer
por: Turner-Ivey, Brittany, et al.
Publicado: (2014) -
Development and implementation of the SUM breast cancer cell line functional genomics knowledge base
por: Ethier, Stephen P., et al.
Publicado: (2020) -
Amplification of WHSC1L1 regulates expression and estrogen‐independent activation of ERα in SUM‐44 breast cancer cells and is associated with ERα over‐expression in breast cancer
por: Irish, Jonathan C., et al.
Publicado: (2016) -
Evaluating the value of Amphiregulin, Phosphatase and Tensin Homologue (PTEN) and P21 Expression for Anti-EGFR Treatment in Metastatic Colorectal Carcinoma
por: Obaya, Ahmed Ali, et al.
Publicado: (2021)